Stylus Medicine launches with $85m to advance in vivo gene editing
Biotech startup Stylus Medicine has launched with $85m in funding to develop a new class of in vivo genetic medicines…
Biotech startup Stylus Medicine has launched with $85m in funding to develop a new class of in vivo genetic medicines…
US President Donald Trump has signed an executive order aimed at reducing prescription drug prices by linking them to what…
Roche is deepening its manufacturing footprint in the US with plans to invest more than $700m in a new production…
In a renewed push to overhaul pharmaceutical pricing in the US, President Donald Trump announced he will sign an executive…
The US Food and Drug Administration (FDA) is moving to tighten oversight of foreign manufacturers supplying the US market by…
Sarepta Therapeutics saw its stock drop by 26% on 6 May after the US Food and Drug Administration (FDA) announced…
UK-based Alchemab has secured a licensing agreement worth up to $415m with Eli Lilly for ATLX-1282, its investigational antibody therapy…
AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it seeks to reduce…
Pliant Therapeutics will cut 45% of its workforce in a sweeping restructuring effort aimed at extending its cash runway, the…
In February 2025, researchers at St Jude Children’s Research Hospital reported the first known in utero use of Roche’s spinal…